How many institutions held SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share in Q2 2025?

3 institutional investors reported SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

Q: What does CUSIP 83422E105 represent in this 13F holders report?

CUSIP 83422E105 is the security identifier for SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 83422E105

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock $0.001 par value per share
Total 13F shares: 733
Total 13F value: $3,569
Share change: +255
SEC-reported price per share: $4.87
Number of holders: 3
Value change: +$1,352
Number of buys: 3
Number of sells: 1
Shares outstanding: 100,767,588

Security key

83422E105

Report period

Q2 2025

Institutions

Top holders

SLDB full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Solid Biosciences Inc. SEC filings Solid Biosciences Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 83422E105

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Invus Global Management, LLC

Disclosed value leader

Bain Capital Life Science...

Comparable rows

15/15

Latest evidence

31 Mar 2025

13D/G 13F 3/4/5 Lead comparable stake: 9.6% 13D/G row: Invus Global Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Invus Global Management, LLC leads the comparable SEC ownership view at 9.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invus Global Management, LLC's linked filing trail.

Comparable ownership Top 5

Invus Global Management, LLC 9.6%

PERCEPTIVE ADVISORS LLC 12%

Bain Capital Life Sciences Invest... 8%

Siren, L.L.C. 7.5%

ADAGE CAPITAL PARTNERS GP, L.L.C. 6.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Invus Global Management, LLC	13D/G Raymond Debbane 13D/G	9.6%	$27,216,371 7,415,905 shares	+$13,457,391	31 Mar 2025
PERCEPTIVE ADVISORS LLC	13F Company 13F	12%	$44,054,590 11,906,646 shares	—	31 Mar 2025
Bain Capital Life Sciences Investors, LLC	3/4/5 13F 10%+ Owner · Company 3/4/5 13F	8% from 13F	$46,252,926 11,478,752 shares mixed-class rows	—	19 Feb 2025
Siren, L.L.C.	13F Individual 13F	7.5%	$27,438,849 7,415,905 shares	—	31 Mar 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	6.8%	$24,899,091 6,729,484 shares	—	31 Mar 2025
Commodore Capital LP	13F Company 13F	5.9%	$21,552,500 5,825,000 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

733

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2025 holders

Holder diff

-4

Investor	Q1 2026 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend